| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |